Tumor microenvironment (TME) is composed of tumor cells, immune cells, cytokines, extracellular matrix, etc. The immune system and the metabolisms of glucose, lipids, amino acids, and nucleotides are integrated in the tumorigenesis and development. Cancer cells and immune cells show metabolic reprogramming in the TME, which intimately links immune cell functions and edits tumor immunology. Recent findings in immune cell metabolism hold the promising possibilities toward clinical therapeutics for treating cancer. This chapter introduces the updated understandings of metabolic reprogramming of immune cells in the TME and suggests new directions in manipulation of immune responses for cancer diagnosis and therapy.
CITATION STYLE
Li, Y., Wan, Y. Y., & Zhu, B. (2017). Immune cell metabolism in tumor microenvironment. In Advances in Experimental Medicine and Biology (Vol. 1011, pp. 163–196). Springer New York LLC. https://doi.org/10.1007/978-94-024-1170-6_5
Mendeley helps you to discover research relevant for your work.